Paying users zone. Data is covered by 
.
Get 1 month access to Gilead Sciences Inc. for $17.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Gilead Sciences Inc. (GILD)
Price to Book Value (P/BV)
since 2005
Difficulty: Beginner
Calculation
Gilead Sciences Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Gilead stockholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2017 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2016 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2015 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2014 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2013 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2012 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2011 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2010 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2009 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2008 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2007 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2006 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2005 | |
= | |
÷ | |
|
= | |
÷ | |
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
1 USD $
2 Data adjusted for splits and stock dividends.
3 Close price on the filing date of Gilead Sciences Inc.’s Annual Report.
Comparison to Competitors
Gilead Sciences Inc., P/BV, long-term trends, comparison to competitors
| Gilead Sciences Inc. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Celgene Corp. | Eli Lilly & Co. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2017 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2016 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2015 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2014 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2013 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2012 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2011 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2010 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2009 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2008 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2007 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2006 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2005 | |
|
|
|
|
|
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Gilead Sciences Inc., P/BV, long-term trends, comparison to sector (Pharmaceuticals & Biotechnology)
| Gilead Sciences Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2018 | |
|
| Dec 31, 2017 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2005 | |
|
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
Comparison to Industry (Health Care)
Gilead Sciences Inc., P/BV, long-term trends, comparison to industry (Health Care)
| Gilead Sciences Inc. | Health Care | |
|---|---|---|
| Dec 31, 2018 | |
|
| Dec 31, 2017 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2005 | |
|
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).